• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型 4-(吡啶基)-4H-苯并[g]色烯-5,10-二酮钌(II)复合物可诱导 518A2 黑素瘤细胞衰老。

A new 4-(pyridinyl)-4H-benzo[g]chromene-5,10-dione ruthenium(II) complex inducing senescence in 518A2 melanoma cells.

机构信息

Organic Chemistry Laboratory, University of Bayreuth, Universitaetsstrasse 30, 95440, Bayreuth, Germany.

Department of Chemistry, Abeda Inamdar Senior College, 2390-B, K.B. Hidayatullah Road, Pune, 411001, India.

出版信息

J Biol Inorg Chem. 2019 Aug;24(5):647-657. doi: 10.1007/s00775-019-01677-y. Epub 2019 Jun 19.

DOI:10.1007/s00775-019-01677-y
PMID:31218441
Abstract

2-Amino-5,10-dihydro-5,10-dioxo-4(pyridine-3-yl)-4H-benzo[g]chromene-3-carbonitrile 5, a cytotoxic lawsone derivative, was reacted with [Ru(p-cymene)Cl] to afford a new Ru(II) 'piano-stool' complex 6 which differed from its ligand 5 by a greater selectivity for highly invasive 518A2 melanoma cells over human dermal fibroblasts in MTT cytotoxicity assays, and by inducing senescence rather than apoptosis in the former. DNA is a likely cellular target of complex 6 as it bound, presumably non-covalently, to linear and circular double-stranded DNA in vitro and as ruthenium was found in the lysate of nuclei of treated 518A2 melanoma cells. It also caused a fivefold increase of reactive oxygen species in these cells, originating from a more persistent redox cycling as visualised by cyclic voltammetry.

摘要

2-氨基-5,10-二氢-5,10-二氧代-4(吡啶-3-基)-4H-苯并[g]色烯-3-甲腈 5 是一种细胞毒性的 lawsone 衍生物,与 [Ru(p-cymene)Cl] 反应得到了一种新的 Ru(II)“钢琴凳”配合物 6,与配体 5 相比,该配合物对高度侵袭性的 518A2 黑色素瘤细胞具有更高的选择性,而对人真皮成纤维细胞的选择性较低。在 MTT 细胞毒性试验中,该配合物诱导 518A2 黑色素瘤细胞衰老而不是凋亡。由于配合物 6 可能非共价结合到体外的线性和环状双链 DNA 上,并且在处理过的 518A2 黑色素瘤细胞核的裂解物中发现了钌,因此 DNA 可能是该配合物的细胞靶标。它还导致这些细胞中活性氧的五倍增加,这源自于通过循环伏安法可视化的更持久的氧化还原循环。

相似文献

1
A new 4-(pyridinyl)-4H-benzo[g]chromene-5,10-dione ruthenium(II) complex inducing senescence in 518A2 melanoma cells.一种新型 4-(吡啶基)-4H-苯并[g]色烯-5,10-二酮钌(II)复合物可诱导 518A2 黑素瘤细胞衰老。
J Biol Inorg Chem. 2019 Aug;24(5):647-657. doi: 10.1007/s00775-019-01677-y. Epub 2019 Jun 19.
2
Biological Potential of Halfsandwich Ruthenium(II) and Iridium (III) Complexes.半夹心钌(II)和铱(III)配合物的生物活性
Anticancer Agents Med Chem. 2016;16(11):1455-1460. doi: 10.2174/1871520615666151029100749.
3
(Arene)Cl₂Ru(II) complexes with N-coordinated estrogen and androgen isonicotinates: interaction with sex hormone binding globulin and anticancer activity.(芳基)二氯钌(II)配合物与 N 配位的雌激素和雄激素异烟酸盐:与性激素结合球蛋白的相互作用和抗癌活性。
Steroids. 2011 Mar;76(4):393-9. doi: 10.1016/j.steroids.2010.12.009. Epub 2010 Dec 22.
4
Ru(II)-Naphthoquinone complexes with high selectivity for triple-negative breast cancer.高选择性识别三阴性乳腺癌的 Ru(II)-萘醌配合物。
Dalton Trans. 2020 Nov 25;49(45):16193-16203. doi: 10.1039/d0dt01091j.
5
Ru( p-cymene) Compounds as Effective and Selective Anticancer Candidates with No Toxicity in Vivo.钌(对伞花烃)化合物是有效的、选择性的抗癌候选物,在体内无毒性。
Inorg Chem. 2018 Nov 5;57(21):13150-13166. doi: 10.1021/acs.inorgchem.8b01270. Epub 2018 Oct 19.
6
Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.含P^P螯合配体的半夹心铱(III)和钌(II)配合物:一类具有异常氧化还原特性的新型强效抗癌剂。
Inorg Chem. 2018 Feb 19;57(4):1705-1716. doi: 10.1021/acs.inorgchem.7b01959. Epub 2018 Feb 5.
7
Modulating the Anticancer Activity of Ruthenium(II)-Arene Complexes.调控钌(II)-芳烃配合物的抗癌活性
J Med Chem. 2015 Apr 23;58(8):3356-65. doi: 10.1021/jm501655t. Epub 2015 Apr 7.
8
Highly Cytotoxic Ruthenium(II)-Arene Complexes from Bulky 1-Pyrenylphosphane Ligands.具有高细胞毒性的钌(II)-芳基配合物来自大位阻的 1-联吡啶基膦配体。
Inorg Chem. 2018 Dec 3;57(23):14786-14797. doi: 10.1021/acs.inorgchem.8b02541. Epub 2018 Nov 16.
9
Heterobimetallic Ru(ii)/Fe(ii) complexes as potent anticancer agents against breast cancer cells, inducing apoptosis through multiple targets.双金属钌(ii)/铁(ii)配合物作为有效的抗癌剂,通过多个靶点诱导乳腺癌细胞凋亡。
Metallomics. 2020 Apr 1;12(4):547-561. doi: 10.1039/c9mt00272c. Epub 2020 Feb 28.
10
Synthesis of NNN Chiral Ruthenium Complexes and Their Cytotoxicity Studies.合成 NNN 手性钌配合物及其细胞毒性研究。
Inorg Chem. 2021 May 17;60(10):7422-7432. doi: 10.1021/acs.inorgchem.1c00698. Epub 2021 Apr 28.

引用本文的文献

1
Curcumin: reclaiming the lost ground against cancer resistance.姜黄素:收复抗癌耐药性方面的失地
Cancer Drug Resist. 2021 Jun 19;4(2):298-320. doi: 10.20517/cdr.2020.92. eCollection 2021.

本文引用的文献

1
New (arene)ruthenium(II) complexes of 4‑aryl‑4H‑naphthopyrans with anticancer and anti-vascular activities.具有抗癌和抗血管活性的 4-芳基-4H-萘并吡喃的新型(芳基)钌(II)配合物。
J Inorg Biochem. 2018 Jul;184:69-78. doi: 10.1016/j.jinorgbio.2018.03.013. Epub 2018 Apr 5.
2
Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics?钌(II)化合物:下一代抗癌金属治疗剂?
J Med Chem. 2018 Jul 26;61(14):5805-5821. doi: 10.1021/acs.jmedchem.7b01689. Epub 2018 Feb 26.
3
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
4
Safety and activity of IT-139, a ruthenium-based compound, in patients with advanced solid tumours: a first-in-human, open-label, dose-escalation phase I study with expansion cohort.钌基化合物 IT-139 在晚期实体瘤患者中的安全性和活性:一项首次人体开放标签剂量递增的 I 期研究及扩展队列研究
ESMO Open. 2017 Feb 23;1(6):e000154. doi: 10.1136/esmoopen-2016-000154. eCollection 2016.
5
Novel Antitumor Platinum(II) Conjugates Containing the Nonsteroidal Anti-inflammatory Agent Diclofenac: Synthesis and Dual Mechanisms of Antiproliferative Effects.含非甾体抗炎药双氯芬酸的新型抗肿瘤铂(II)缀合物:合成及抗增殖作用的双重机制
Inorg Chem. 2017 Feb 6;56(3):1483-1497. doi: 10.1021/acs.inorgchem.6b02553. Epub 2017 Jan 19.
6
Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2016.黑色素瘤的诊断与治疗。基于循证医学的欧洲多学科专家共识指南——2016 年更新版
Eur J Cancer. 2016 Aug;63:201-17. doi: 10.1016/j.ejca.2016.05.005. Epub 2016 Jun 29.
7
Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature.欧洲皮肤恶性黑色素瘤患者的阶段特异性生存和复发——文献系统综述
Clin Epidemiol. 2016 May 26;8:109-22. doi: 10.2147/CLEP.S99021. eCollection 2016.
8
Anticancer Activity and Modes of Action of (arene) ruthenium(II) Complexes Coordinated to C-, N-, and O-ligands.与碳、氮和氧配体配位的(芳烃)钌(II)配合物的抗癌活性及作用方式
Mini Rev Med Chem. 2016;16(10):804-14. doi: 10.2174/138955751610160503004623.
9
Morphological and Functional Characteristic of Senescent Cancer Cells.衰老癌细胞的形态学和功能特征
Curr Drug Targets. 2016;17(4):377-87. doi: 10.2174/1389450116666151019094724.
10
Senescence from G2 arrest, revisited.重新审视G2期阻滞导致的衰老。
Cell Cycle. 2015;14(3):297-304. doi: 10.1080/15384101.2014.1000134.